Yahoo India Web Search

Search results

    • FDA clears Artelo’s FABP5 inhibitor trial

      FDA clears Artelo’s FABP5 inhibitor trial

      Clinical Trials Arena· 3 hours ago

      FABP5/FABP7 inhibitors have also been hinted as having potential therapeutic potential in multiple sclerosis, based on mouse models. "FDA clears Artelo’s...